CCSD code 0002T: Immunoscore diagnostic billing guide

Key Takeaways

CCSD code 0002T is the UK private healthcare diagnostic code assigned to the Immunoscore assay, a validated colorectal cancer prognostic test developed by HalioDx.

The code was granted by the CCSD Working Group in January 2020 following a review of clinical evidence for the Immunoscore assay.

Pre-authorization is typically required before using CCSD code 0002T; always confirm with the patient’s insurer before ordering the test.

Pabau’s claims management software helps UK private practices track CCSD code submissions, flag missing documentation, and reduce claim rejections.

CCSD code 0002T: definition and clinical scope

CCSD code 0002T is the diagnostic code assigned by the Clinical Coding and Schedule Development (CCSD) Working Group to the Immunoscore assay, a laboratory test used to assess the immune response in colorectal cancer tumor tissue. The code sits in the CCSD Diagnostic Schedule, not the Procedural Schedule, a distinction that matters for claim routing and fee schedule lookup.

This guide covers what the code covers, which insurers recognize it, what documentation is required, and how to submit a claim correctly.

The Immunoscore assay: what CCSD code 0002T covers

The Immunoscore assay was developed by HalioDx, an immuno-oncology diagnostics company. It quantifies the density of cytotoxic and memory T-lymphocytes at the tumor core and invasive margin of colorectal cancer specimens, producing a score on a scale from Immunoscore 0 (IS0) to Immunoscore 4 (IS4). Higher scores correlate with better prognosis.

In January 2020, HalioDx announced that the CCSD Working Group had reviewed the clinical evidence for the assay and formally granted it a dedicated diagnostic CCSD code. That code is 0002T.

Before the code was granted, UK private consultants ordering the Immunoscore assay had no standardized way to bill for it within the CCSD framework. The 0002T designation resolved that gap and enabled the test to appear on recognized insurer fee schedules. Note: CCSD code grant is not equivalent to NICE appraisal or MHRA approval; those are separate regulatory processes.

0002T vs adjacent CCSD codes

In the CCSD Diagnostic Schedule, the four-digit stem identifies the individual test and the trailing letter identifies the specimen type (for example, B for blood, S for skin, and O for other body fluids). The “T” in 0002T denotes a tissue specimen, consistent with the Immunoscore assay being performed on colorectal tumor tissue. This is unrelated to the deleted US CPT Category III code 0002T, which happens to share the same number. For a CCSD code frequently confused with its US CPT namesake, see the CCSD code 0001T reference page.

The key practical difference: 0002T is a diagnostic code. It must be submitted on a diagnostic test invoice, not on a surgical or procedural invoice. Mixing procedural and diagnostic codes on the same claim line is a common billing error that triggers rejection.

UK insurers and CCSD code 0002T recognition

The CCSD schedule provides the coding framework; individual insurers decide whether and at what fee they will reimburse a given code. Recognition status for newer codes like 0002T can vary by insurer and changes over time as clinical evidence accumulates. Always verify current recognition directly with the patient’s insurer before ordering the test.

The following insurers publish CCSD-based fee schedules and are the primary payers likely to be relevant when billing 0002T in UK private practice. For up-to-date code recognition status, use each insurer’s portal directly:

• Bupa: Use the Bupa code search portal to confirm 0002T recognition and current fee. Bupa is the largest UK private health insurer and typically one of the first to adopt new CCSD-recognized codes.
• AXA Health: Check the AXA Health specialist procedure codes portal for diagnostic code recognition. AXA Health uses CCSD codes and publishes separate fee chapters for diagnostics.
• Aviva UK Health: Review the Aviva fee schedule and invoicing requirements. Aviva aligns with CCSD and requires CCSD codes on all submitted invoices.
• Allianz Care UK: The Allianz Care UK published fee schedule (effective December 2024) is CCSD-based and lists recognized diagnostic codes and fees.
• H3 Insurance: H3’s procedure and diagnostic coding is based on the CCSD schedule. Contact H3 directly or consult their provider documentation to confirm 0002T recognition.
• Cigna UK: Uses a CCSD-based fee schedule. Verify recognition status through Cigna’s UK provider resources before submission.

For any insurer not listed here, check whether they use the CCSD Diagnostic Schedule as their coding standard. If they do, 0002T should be submittable. Insurers that use non-CCSD coding frameworks will require a different code or a manual mapping.

Pre-authorization for CCSD code 0002T

Most UK private insurers require pre-authorization (also called prior authorization) for diagnostic tests beyond routine blood panels, particularly for tests that are relatively new to the CCSD schedule. Given that 0002T was only added in 2020, pre-authorization requirements may still apply at most major insurers.

Pre-authorization requirements vary by insurer, policy year, and patient plan tier. Submitting a claim for 0002T without a valid pre-authorization reference number, where one is required, is the most common reason for rejection at this code. Build pre-authorization verification into the patient journey before the test is ordered. Good private practice management workflows capture this reference at the point of referral, not after the invoice is sent.

Manage CCSD billing without the paperwork

Pabau helps UK private practices track CCSD code submissions, store pre-authorization references against patient records, and flag missing documentation before claims go out. Fewer rejections, less admin.

Book a demo

Documentation requirements for CCSD code 0002T claims

A valid CCSD code gets a claim to the insurer’s intake system. Thorough documentation gets it paid. For CCSD code 0002T, the documentation burden reflects the fact that it covers a specialist oncology diagnostic test, not a routine procedure.

The following documentation should accompany or be available to support any 0002T claim:

• Consultant referral letter: A referring consultant’s letter or clinical note explaining the clinical indication for the Immunoscore assay. This should confirm the patient’s colorectal cancer diagnosis, staging context, and the clinical question the assay is intended to answer.
• Pre-authorization reference number: Where pre-authorization was granted by the insurer, include the authorization number on the invoice. Without this, the claim will likely be rejected before clinical review begins.
• Patient policy details: Insurer membership or policy number, patient date of birth, and full name as they appear on the insurance policy. Mismatches between invoice and policy data are a frequent cause of delay.
• Test report or laboratory confirmation: Some insurers require evidence that the test was performed. Retain a copy of the Immunoscore assay report in the patient record. This is also required for good clinical governance and patient records management.
• Invoice with correct CCSD code: The invoice must state code 0002T under the diagnostic section, not the procedural section. Include the date the test was performed, not the date the report was issued.
• Consultant GMC number: Most UK private insurers require the referring or ordering consultant’s GMC registration number on the invoice for traceability.

Maintaining complete documentation is not just a billing requirement. Under UK data protection law, patient records must be accurate, complete, and accessible. Using digital forms to capture referral information and consent at the point of consultation reduces the risk of documentation gaps appearing only when the invoice is prepared. For UK-specific compliance requirements, the GDPR checklist for UK clinics covers the key record-keeping obligations that apply to private practice.

How to submit a claim using CCSD code 0002T

Claim submission for CCSD diagnostic codes follows the same general workflow as procedural CCSD codes, with one key difference: 0002T must appear on a diagnostic invoice, not a surgical episode invoice. Mixing the two in a single submission is a reliable path to rejection.

Step-by-step claim workflow

1. Confirm pre-authorization. Before the test is ordered, contact the patient’s insurer to confirm that the Immunoscore assay is covered under the patient’s plan and obtain a pre-authorization reference. Record this number in the patient’s file.
2. Order the test and retain documentation. Once the assay is performed by the laboratory, retain the test report. Record the test date accurately; this is the date that goes on the invoice, not the report issue date.
3. Prepare a diagnostic invoice. Create a separate invoice for the diagnostic test. Code the test as 0002T on the CCSD Diagnostic Schedule. Include the consultant’s GMC number, the patient’s insurer details, the pre-authorization reference, and the test date.
4. Submit to the insurer. Submit via the insurer’s preferred channel. Most major UK private insurers now accept electronic submission. Bupa, AXA Health, and Aviva all support electronic claim submission through their provider portals. Paper submission remains available but slows processing.
5. Track the claim and respond to queries. Monitor the claim status. If the insurer requests additional clinical information (for example, the consultant referral letter or assay report), respond promptly. Delays in responding to information requests are the second most common reason claims remain unpaid after submission.

Using claims management software that supports CCSD coding can reduce the error rate at step 3. Systems that allow CCSD codes to be attached to patient records and automatically validate invoice completeness before submission catch missing fields before they become rejection reasons. For clinics handling a high volume of private billing across multiple codes, this is where admin time is most effectively reduced.

Common billing errors to avoid

• Submitting on a procedural invoice: 0002T is a diagnostic code. It belongs on a diagnostic invoice. This is the single most common error for new diagnostic codes.
• Missing the pre-authorization reference: Most insurers require this for newer diagnostics. A claim without it will be returned.
• Wrong invoice date: Use the test date (when the assay was performed), not the report date or consultation date.
• Patient details mismatch: The name, date of birth, and policy number on the invoice must match exactly what the insurer holds. A single-character discrepancy can trigger a manual review or rejection.
• Assuming universal recognition: CCSD code grant does not mean every insurer automatically covers the test. Confirm recognition with the specific insurer before billing.

For oncology-focused private practices, building a CCSD compliance workflow that covers both procedural and diagnostic codes is part of broader compliance management. Practice management software with CCSD support reduces the manual work involved in maintaining separate billing streams for diagnostic and procedural codes.

The CCSD schedule and how it works

Understanding where 0002T sits within the broader CCSD framework helps avoid coding errors that stem from schedule misclassification. The CCSD schedule is the industry-standard coding framework for UK private healthcare, maintained by the CCSD Working Group. It covers two main schedules: procedural codes and diagnostic codes.

The CCSD Technical Guide (updated October 2025) sets out the coding conventions, business rules, and chapter structure for both schedules. According to the Technical Guide, the code in question sits in chapter 35 of the Diagnostic Schedule. Practitioners accessing the schedule directly need to register with the CCSD to use the full search function, as the schedule is available only to registered users.

New codes are added following a formal code request process. Providers, manufacturers, and clinical bodies can submit code requests through the CCSD website. The Working Group reviews the clinical evidence and, if satisfied, grants a code and assigns it to the appropriate chapter. The HalioDx announcement in 2020 confirms this process was followed for 0002T.

Conclusion

CCSD code 0002T resolves a specific billing gap: it gives UK private healthcare providers a standardized way to invoice the Immunoscore colorectal cancer assay under the CCSD Diagnostic Schedule. Used correctly, with pre-authorization confirmed, documentation complete, and the code placed on a diagnostic invoice, it should process through major insurers without difficulty.

Where claims for this code fail, it is almost always due to a documentation gap or a procedural/diagnostic invoice mix-up, not a dispute about clinical validity. Pabau’s claims management tools help UK private practices catch these errors before submission. To see how Pabau handles CCSD billing workflows, book a demo.

Continue your research

Need a full reference for Bupa CCSD codes? Bupa CCSD codes: complete guide for UK clinics covers how to find codes, avoid denial triggers, and submit electronically to Bupa.

Managing multi-site UK private billing? Multi-location management in Pabau lets you centralize CCSD billing workflows across multiple clinic sites from a single system.

Looking for a broader compliance framework for UK private practice? GDPR compliance checklist for UK clinics outlines the key data and record-keeping obligations that apply to private healthcare providers.

Frequently Asked Questions